Dr. Jingru Zhang 张菁茹
Chief Physician
Gynecology (IV), Liaoning Cancer Hospital & Institute, Shenyang
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Comprehensive treatment of gynecologic malignancies, including advanced ovarian cancer surgery, pelvic and para-aortic lymph node dissection, enhanced recovery after surgery, and management of radiation enteritis.
Dr. Zhang is a Chief Physician with a PhD in Pathology from China Medical University (2008). Dr. Zhang studied Enhanced Recovery After Surgery at Nanjing General Hospital in 2012. Research focuses on lymph node metastasis in endometrial and cervical cancer. Dr. Zhang has published seven papers in national core journals and one SCI paper.
Name order: in Chinese the family name comes first (Zhang Jingru). Papers usually list the name as Jingru Zhang or Zhang J.
Selected publications
17 papers on PubMed matched by name and affiliation; 10 as first or senior author since 2016. Most recent first- or senior-author papers:
- Sichuan Da Xue Xue Bao Yi Xue Ban, 2026 (senior author): [The Role of Cuproptosis Related Key Genes in Ovarian Cancer and the Construction of a Prognostic Model]. PubMed 42369705
- Front Oncol, 2025 (senior author): Clinical analysis of different intestinal reconstruction methods after primary cytoreductive surgery combined with rectal resection for advanced ovarian cancer. PubMed 39931090
- Gynecol Obstet Invest, 2023 (senior author): LINC01857 Exacerbates the Malignant Behaviors of Endometrial Carcinoma Cells by Sponging miR-19b-3p and Recruiting ELAVL1 to Upregulate MYCN. PubMed 36574754
- J Gene Med, 2021 (senior author): LINC00958 promotes endometrial cancer cell proliferation and metastasis by regulating the miR-145-3p/TCF4 axis. PubMed 33885186
- Front Cell Dev Biol, 2020 (senior author): Long Non-coding RNA LINC01969 Promotes Ovarian Cancer by Regulating the miR-144-5p/LARP1 Axis as a Competing Endogenous RNA. PubMed 33614632
- J Cell Biochem, 2020 (first author): The lncRNA SNHG15/miR-18a-5p axis promotes cell proliferation in ovarian cancer through activating Akt/mTOR signaling pathway. PubMed 33135285
- Front Cell Dev Biol, 2020 (senior author): CircASH2L Promotes Ovarian Cancer Tumorigenesis, Angiogenesis, and Lymphangiogenesis by Regulating the miR-665/VEGFA Axis as a Competing Endogenous RNA. PubMed 33330483
- Cell Cycle, 2020 (first author): Elevation of microRNA-512-5p inhibits MUC1 to reduce radioresistance in cervical cancer. PubMed 32126879
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion